GlassScriptPhysician profile
Jennifer A Reed
NPI 1891095741
$1,033.73
in general payments reported to CMS, 2019-2025
11 companies · $268 in 2025
The $268 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $273 · 2022: $257 · 2023: $81.98 · 2024: $154 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478 · Education: $25.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $477.95 |
| Education | $25.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $199.96 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $165.05 | 2021-2024 | Spravato |
| Axsome Therapeutics, INC. | $162.70 | 2023-2024 | Auvelity, Sunosi |
| Janssen Scientific Affairs, LLC | $131.92 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $123.17 | 2025 | Xifaxan |
| Otsuka America Pharmaceutical, INC. | $109.97 | 2025 | Rexulti |
| Supernus Pharmaceuticals, INC. | $36.36 | 2021-2022 | |
| Syndax Pharmaceuticals, INC. | $34.75 | 2025 | |
| Sunovion Pharmaceuticals INC. | $26.77 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.65 | 2024 | Trintellix |
| Lundbeck LLC | $17.43 | 2023 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.